Gian Luca Rampioni Vinciguerra

Pubblicazioni

Titolo	Pubblicato in	Anno
Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice	NPJ BREAST CANCER	2024
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma	SIGNAL TRANSDUCTION AND TARGETED THERAPY	2024
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance	SIGNAL TRANSDUCTION AND TARGETED THERAPY	2023
Clear cell carcinoma of the stomach: a rare tumor variant imparting poor prognosis	ACTA CHIRURGICA BELGICA	2023
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation	CANCER COMMUNICATIONS	2023
A novel auxin-inducible degron system for rapid, cell cycle-specific targeted proteolysis	CELL DEATH AND DIFFERENTIATION	2023
Role of Fra-2 in cancer	CELL DEATH AND DIFFERENTIATION	2023
CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review	FRONTIERS IN ONCOLOGY	2022
EMILIN-1 deficiency promotes chronic inflammatory disease through TGFβ signaling alteration and impairment of the gC1q/α4β1 integrin interaction	MATRIX BIOLOGY	2022
Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer	CANCER RESEARCH	2022
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer	JOURNAL OF PATHOLOGY	2021
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC	EMBO MOLECULAR MEDICINE	2021
p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer	CELL DEATH & DISEASE	2021
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients. Results from the Phase IV MITO16A/ManGO OV-2 Translational Study	CANCERS	2021
Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to CDK4/6 inhibitors in luminal breast cancer	CANCER RESEARCH	2020
TIMP-1 is Overexpressed and Secreted by Platinum Resistant Epithelial Ovarian Cancer Cells	CELLS	2020
Stathmin is required for normal mouse mammary gland development and D16Her2-driven tumorigenesis	CANCER RESEARCH	2019
P27kip1 at the crossroad between actin and microtubule dynamics	CELL DIVISION	2019
USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability	SCIENCE ADVANCES	2019
Pathologist second opinion significantly alters clinical management of pT1 endoscopically resected colorectal cancer	VIRCHOWS ARCHIV	2019